Edward Huey
Butler Hospital Memory and Aging Program · Brown University · Columbia University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Edward Huey as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:11 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05457998 · BioFINDER-Brown: Examination of Alzheimer's Disease BiomarkersButler Hospital · enrolling by invitation · Alzheimer Disease, Mild Cognitive Impairment, Dementia · principal investigator
- Ph2NCT02862210 · Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal DementiaColumbia University · completed · Frontotemporal Dementia (FTD) · principal investigator
- Ph2NCT02676843 · Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT MutationsColumbia University · completed · Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD), Tauopathies · principal investigator
- Ph2NCT00604591 · Effects of Tolcapone on Frontotemporal DementiaColumbia University · completed · Frontotemporal Lobar Degeneration · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Genetic basis of neuropsychiatric symptoms in Alzheimer's diseaseU01AG079850 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2023 to 2026 · $740,458 awarded in 2026Same name and institution; not confirmed by an ID
- Using RDoC Negative and Positive Valence Paradigms to Investigate the Mechanisms of Neuropsychiatric Symptoms (NPS) in Alzheimer's Disease and Related DementiasR01MH120794 · NIMH · BROWN UNIVERSITY · fiscal years 2019 to 2023 · $439,032 awarded in 2023Same name and institution; not confirmed by an ID
- Neuroanatomical associations with the factor structure underlying neuropsychiatric symptoms in Alzheimer's diseaseR01AG062268 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2018 to 2022 · $394,829 awarded in 2022Same name and institution; not confirmed by an ID
- Outreach, Recruitment and Engagement CoreP30AG066462 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2020 to 2022 · $150,639 awarded in 2022Same name and institution; not confirmed by an ID
- Examination of the earliest symptoms and biomarkers of FTLD MAPT carriersR01NS076837 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2012 to 2016 · $547,222 awarded in 2016Grant number is on one of their registry trials
- Investigation of the dopamine system in frontotemporal dementiaR00NS060766 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2009 to 2011 · $234,108 awarded in 2011Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:11 UTC. The ranking covers the 200 most relevant of 9 PubMed records, and a shared surname and initials can bring in a namesake. All 9 on PubMed
- 57 citationsRCR 13.8
- Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial.Am J Geriatr Psychiatry · 202250 citationsRCR 4.7
- Stimulant treatment of frontotemporal dementia in 8 patients.J Clin Psychiatry · 200845 citationsRCR 1.2
- No effect of DC brain polarization on verbal fluency in patients with advanced frontotemporal dementia.Clin Neurophysiol · 200731 citationsRCR 0.9
- 21 citationsRCR 7.4
- Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial.JAMA · 202616 citationsRCR 8.0
- Tolcapone Treatment for Cognitive and Behavioral Symptoms in Behavioral Variant Frontotemporal Dementia: A Placebo-Controlled Crossover Study.J Alzheimers Dis · 202013 citationsRCR 0.7
- Feasibility and tolerability of low-dose lithium for the treatment of agitation and abnormal motor behaviors in Frontotemporal Dementia.Int Rev Psychiatry · 20254 citationsRCR 1.2
- Valacyclovir Treatment in Mild Cognitive Impairment: The VALMCI Randomized Clinical Trial.Alzheimer Dis Assoc Disord · 2026